Review

Published on 18 Feb 2021

Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review

in Pharmacology of Anti-Cancer Drugs

Tian-Jia Liu
Shuang Hu
Zhi-Dong Qiu
Da Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.634936

3,989 views
12 citations

Mini Review

Published on 18 Feb 2021

The Hypoxic Microenvironment of Breast Cancer Cells Promotes Resistance in Radiation Therapy

in Pharmacology of Anti-Cancer Drugs

Cordell Gilreath
Marjan Boerma
Zhiqiang Qin
M. Keith Hudson
Shanzhi Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.629422

3,918 views
24 citations

Original Research

Published on 17 Feb 2021

Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer

in Pharmacology of Anti-Cancer Drugs

Feng Yang
Ziyu Zhao
Shaoyi Cai
Li Ling
Leying Hong
Liang Tao
Qin Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.576565

4,549 views
12 citations

Review

Published on 11 Feb 2021

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects

in Pharmacology of Anti-Cancer Drugs

Heming Wang
Sinuo Chen
Jiayi Wei
Guangqi Song
Yicheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.632187

14,460 views
26 citations

Original Research

Published on 11 Feb 2021

Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

in Pharmacology of Anti-Cancer Drugs

Huijuan Liu
Honglian Tao
Hongqi Wang
Yuyan Yang
Ru Yang
Xintong Dai
Xiujuan Ding
Haidong Wu
Shuang Chen
Tao Sun

Frontiers in Oncology

doi 10.3389/fonc.2020.619317

13,477 views
25 citations

Original Research

Published on 10 Feb 2021

MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin

in Pharmacology of Anti-Cancer Drugs

Peng Liu
Fuao Cao
Jinke Sui
Yonggang Hong
Qizhi Liu
XianHua Gao
Haifeng Gong
Liqiang Hao
Zheng Lou
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.552944

2,419 views
9 citations

Original Research

Published on 09 Feb 2021

RETRACTED: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

in Pharmacology of Anti-Cancer Drugs

Bo Li
Xin Zhao
Lei Zhang
Wen Cheng

Frontiers in Oncology

doi 10.3389/fonc.2020.588533

3,620 views
15 citations

Original Research

Published on 05 Feb 2021

Population Pharmacokinetics and Exposure–Safety Relationship of Paclitaxel Liposome in Patients With Non-small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Haiyan Zhou
Jiaqing Yan
Wei Chen
Jun Yang
Min Liu
Yuan Zhang
Xin Shen
Yinglin Ma
Xingsheng Hu
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.01731

4,407 views
8 citations

Original Research

Published on 01 Feb 2021

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

in Pharmacology of Anti-Cancer Drugs

Victor M. Matias-Barrios
Mariia Radaeva
Yi Song
Zaccary Alperstein
Ahn R. Lee
Veronika Schmitt
Joseph Lee
Fuqiang Ban
Ning Xie
Jianfei Qi

Frontiers in Oncology

doi 10.3389/fonc.2020.633142

12,830 views
29 citations

Case Report

Published on 01 Feb 2021

Case Report: Herceptin as a Potentially Valuable Adjuvant Therapy for a Patient With Human Epidermal Growth Factor Receptor 2-Positive Advanced Esophageal Squamous Cell Carcinoma

in Pharmacology of Anti-Cancer Drugs

Li Han
Chi Pan
Qingtao Ni
Tao Yu

Frontiers in Oncology

doi 10.3389/fonc.2020.600459

4,327 views
3 citations

Original Research

Published on 01 Feb 2021

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy

in Pharmacology of Anti-Cancer Drugs

Shousheng Liu
Jinfa Lai
Ning Lyu
Qiankun Xie
Huijiao Cao
Dabiao Chen
Meng He
Bei Zhang
Ming Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.582504

4,460 views
23 citations

Original Research

Published on 29 Jan 2021

Overexpression of LncRNA BM466146 Predicts Better Prognosis of Breast Cancer

in Pharmacology of Anti-Cancer Drugs

Yunxiang Zhang
Xiaotong Dong
Yang Wang
Liquan Wang
Guiyan Han
Lvcheng Jin
Yanping Fan
Guodong Xu
Dawei Yuan
Jie Zheng

Frontiers in Oncology

doi 10.3389/fonc.2020.628757

3,233 views
12 citations

Mini Review

Published on 27 Jan 2021

Novel Combination Therapies for the Treatment of Bladder Cancer

in Pharmacology of Anti-Cancer Drugs

Mei Peng
Di Xiao
Yizhi Bu
Jiahui Long
Xue Yang
Shuhe Lv
Xiaoping Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.539527

14,284 views
32 citations

Original Research

Published on 25 Jan 2021

LINC00667 Sponges miR-4319 to Promote the Development of Nasopharyngeal Carcinoma by Increasing FOXQ1 Expression

in Pharmacology of Anti-Cancer Drugs

Bing Liao
Yun Yi
Lei Zeng
Zhi Wang
Xinhua Zhu
Jianguo Liu
Bingbin Xie
Yuehui Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.632813

2,865 views
6 citations

Original Research

Published on 05 Jan 2021

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy

in Pharmacology of Anti-Cancer Drugs

Dong Song
Xiaxia Man
Meng Jin
Qian Li
Han Wang
Ye Du

Frontiers in Oncology

doi 10.3389/fonc.2020.592556

4,118 views
8 citations

Original Research

Published on 21 Dec 2020

RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling

in Pharmacology of Anti-Cancer Drugs

Ling Wang
Xiaoke Chai
Run Wan
Hong Zhang
Cong Zhou
Lin Xiang
Maswikiti Ewetse Paul
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2020.595718

5,611 views
27 citations

Navigation group

Articles

Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review

The Hypoxic Microenvironment of Breast Cancer Cells Promotes Resistance in Radiation Therapy

Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects

Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin

RETRACTED: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Population Pharmacokinetics and Exposure–Safety Relationship of Paclitaxel Liposome in Patients With Non-small Cell Lung Cancer

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

Case Report: Herceptin as a Potentially Valuable Adjuvant Therapy for a Patient With Human Epidermal Growth Factor Receptor 2-Positive Advanced Esophageal Squamous Cell Carcinoma

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy

Overexpression of LncRNA BM466146 Predicts Better Prognosis of Breast Cancer

Novel Combination Therapies for the Treatment of Bladder Cancer

LINC00667 Sponges miR-4319 to Promote the Development of Nasopharyngeal Carcinoma by Increasing FOXQ1 Expression

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy

RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling